Trade Corvus Pharmaceuticals, Inc. - CRVS CFD

Trading Conditions

• Type: CFD
• Spread: 0.0896
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 15.3702
• Open: 15.1202
• 1-Year Change: 221.13%
• Day's Range: 13.8002 - 15.1202

What is Corvus Pharmaceuticals, Inc. (CRVS)?

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of immuno-oncology therapies. The company focuses on creating novel treatments that harness the immune system to target and eliminate cancer cells. Corvus employs a research platform aimed at identifying and developing small molecule drugs that modulate immune responses. Its pipeline includes candidates designed to treat various types of cancer, with an emphasis on enhancing the efficacy of existing immunotherapies. The company collaborates with academic institutions and industry partners to advance its drug development programs.

Corvus Pharmaceuticals, Inc. Stock Price Today: Live Overview

The price today is shaped by Corvus Pharmaceuticals, Inc.'s price action, currently at $14.0898. The daily trading range lies between $13.7202 and $15.2402 with a change of -7.9136%.

FAQ: Corvus Pharmaceuticals, Inc. (CRVS)

What is the current price of CRVS stock?

The last traded price is $14.0898.

Does CRVS pay dividends?

Corvus Pharmaceuticals, Inc. does not pay dividends.

Does CRVS have a formal corporate presence or regional headquarters in the UAE?

Corvus Pharmaceuticals, Inc. has no registered presence or subsidiary in the UAE and operates via distributors.

What is CRVS best known for?

The company is most famous for its development of immuno-oncology therapies.

What assets are typically shown together with CRVS?

Commonly shown alongside CRVS: PIMCO 25+ Year Zero Coupon U.S. Treasury Index Exchange-Traded Fund, AbCellera Biologics Inc, Valneva SE